Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Ferguson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cardiology in Review|February 10, 2012
Vasopressor use in adult patientsNadia Ferguson-Myrthil
Cardiology in Review|October 8, 2010
Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptanNadia Ferguson-Myrthil
Cardiology in Review|June 13, 2017
Droxidopa for Symptomatic Neurogenic HypotensionNadia Ferguson-Myrthil
Cardiology in Review|February 7, 2014
Canagliflozin: a new class of antidiabetic agent targeting the sodium-glucose cotransporterYuliana Toderika, Nadia Ferguson
Annals of the American Thoracic Society|January 31, 2025
Food for Thought: Toward a More Nuanced Approach to Propofol-associated HypertriglyceridemiaAri Moskowitz, Nadia Ferguson
Cardiology in Review|January 3, 2019
Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory ShockSaira C Khalique, Nadia Ferguson
Lung|January 26, 2020
Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic CoughPeter Dicpinigaitis, Imran Satia, Nadia Ferguson
The Annals of Pharmacotherapy|November 20, 2020
Safety of High-Dose Unfractionated Heparin for Prophylaxis of Venous Thromboembolism in Hospitalized Obese PatientsTeresa Regis, Pavel Goriacko, Nadia Ferguson
Critical Care Medicine|February 15, 2020
The authors replyPeter V Dicpinigaitis, Nadia Ferguson, Nail Cemalovic, et al.
Critical Care Medicine|October 1, 2019
Diabetes Insipidus After Discontinuation of Vasopressin Infusion for Treatment of ShockHannah Ferenchick, Nail Cemalovic, Nadia Ferguson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiology in Review|February 10, 2012
Vasopressor use in adult patientsNadia Ferguson-Myrthil
Cardiology in Review|October 8, 2010
Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptanNadia Ferguson-Myrthil
Cardiology in Review|June 13, 2017
Droxidopa for Symptomatic Neurogenic HypotensionNadia Ferguson-Myrthil
Cardiology in Review|February 7, 2014
Canagliflozin: a new class of antidiabetic agent targeting the sodium-glucose cotransporterYuliana Toderika, Nadia Ferguson
Annals of the American Thoracic Society|January 31, 2025
Food for Thought: Toward a More Nuanced Approach to Propofol-associated HypertriglyceridemiaAri Moskowitz, Nadia Ferguson
Cardiology in Review|January 3, 2019
Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory ShockSaira C Khalique, Nadia Ferguson
Lung|January 26, 2020
Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic CoughPeter Dicpinigaitis, Imran Satia, Nadia Ferguson
The Annals of Pharmacotherapy|November 20, 2020
Safety of High-Dose Unfractionated Heparin for Prophylaxis of Venous Thromboembolism in Hospitalized Obese PatientsTeresa Regis, Pavel Goriacko, Nadia Ferguson
Critical Care Medicine|February 15, 2020
The authors replyPeter V Dicpinigaitis, Nadia Ferguson, Nail Cemalovic, et al.
Critical Care Medicine|October 1, 2019
Diabetes Insipidus After Discontinuation of Vasopressin Infusion for Treatment of ShockHannah Ferenchick, Nail Cemalovic, Nadia Ferguson, et al.
Pageof 2